Apply for active substance renewal by the deadlines to keep products on the NI market Under the EU BPR, active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under EU BPR. This affects NI: - 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product types 7 and 10
28 December 2023
- 2-bromo-ethanoic acid (Bromoacetic acid) (CAS 79-08-3 EC 201-175-8) in product type 4
28 December 2023
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 6
28 December 2023
- 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether (Etofenprox) (CAS 80844-07-1 EC 407-980-2) in product type 18
28 December 2023
- Benzoic acid (CAS 65-85-0 EC 200-618-2) in product types 3 and 4
28 December 2023
- Copper sulphate pentahydrate (CAS 7758-99-8 EC 231-847-6) in product type 2
28 December 2023
- Nonanoic acid (Pelargonic acid) (CAS 112-05-0 EC 203-931-2) in product type 2
29 March 2024
- (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin) (CAS 210880-92-5 EC 433-460-1) in product type 18
29 March 2025
- 2-methyl-2H-isothiazol-3-one (MIT) (CAS 2682-20-4 EC 220-239-6) in product type 13
29 March 2025
- Glutaral (Glutaraldehyde) (CAS 111-30-8 EC 203-856-5) in product types 2, 3, 4, 6, 11 and 12
29 March 2025
- N-(trichloromethylthio)phthalimide (Folpet) (CAS 133-07-3 EC 205-088-6) in product types 7 and 9
29 March 2025
Any person, company or task force/consortium can support an active substance/product type combination for renewal it doesnt have to be the original supporter. Check the EU Article 95 List to see who the original supporters were. If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under EU BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products of the relevant product types in Northern Ireland. |